ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $8,933,000 | -7.9% | 150,001 | +5.5% | 5.37% | -19.5% |
Q2 2021 | $9,701,000 | -14.3% | 142,246 | -12.8% | 6.67% | +13.9% |
Q1 2021 | $11,320,000 | +45.5% | 163,135 | +61.1% | 5.86% | +65.1% |
Q4 2020 | $7,779,000 | +11.5% | 101,245 | +8.5% | 3.55% | -20.9% |
Q3 2020 | $6,979,000 | -35.9% | 93,308 | -46.0% | 4.49% | -46.2% |
Q2 2020 | $10,884,000 | +3.7% | 172,896 | -30.8% | 8.34% | -27.3% |
Q1 2020 | $10,494,000 | +441.2% | 249,866 | +485.3% | 11.48% | +230.3% |
Q4 2019 | $1,939,000 | +160.3% | 42,688 | +162.3% | 3.48% | +117.6% |
Q3 2019 | $745,000 | – | 16,272 | – | 1.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |